# Microsidd HCV Rapid Test Kit – 50 Tests | Anti-HCV Professional IVD ## Professional Anti-HCV Antibody Rapid Screening Test The **Microsidd HCV Rapid Test Kit – 50 Tests** is a professional-use in-vitro diagnostic rapid test intended for the **qualitative detection of antibodies to Hepatitis C Virus (anti-HCV)** in compatible human specimens. The test uses **rapid immunochromatographic lateral-flow technology** to support initial hepatitis C antibody screening in diagnostic laboratories, hospitals, clinics, blood-bank environments where applicable, antenatal screening programmes, public-health programmes and other professional healthcare settings. This institutional **50-test pack** is intended for trained healthcare and laboratory personnel. **Important:** A reactive anti-HCV screening result does **not by itself confirm current hepatitis C infection**. Appropriate follow-up testing, generally including an **HCV RNA test**, is required to determine whether active HCV infection is present. # Product Identification **Brand:** Microsidd **Product:** HCV Rapid Test Kit **Product Type:** Hepatitis C Antibody Rapid Test **Category:** Rapid Diagnostic Tests / Infectious Disease Testing **Target Marker:** Anti-HCV Antibodies **Disease Area:** Hepatitis C **Technology:** Immunochromatographic Lateral Flow **Result Type:** Qualitative Screening **Format:** Single-Use Rapid Test Device **Pack Size:** 50 Tests **Intended Use:** Professional In-Vitro Diagnostic Use Only **Seller / Brand Owner:** Microsidd India **Location:** RT Nagar, Bengaluru, Karnataka, India > **Specimen type, specimen volume, buffer quantity, reading time, sensitivity/specificity and storage temperature should be taken only from the package insert supplied with the exact current Microsidd HCV 50T batch.** # What Is the Microsidd HCV Rapid Test? The Microsidd HCV Rapid Test is an antibody-screening test designed to detect **anti-HCV antibodies** associated with exposure to Hepatitis C Virus. It is used as an **initial screening test**. A reactive antibody result means that antibodies associated with HCV have been detected, but it does not determine whether the person: - currently has active HCV infection - had a previous infection that has cleared - requires antiviral treatment - has a particular HCV viral load - has liver damage Determining current infection requires appropriate follow-up testing. # Important: Anti-HCV Antibody Is Not the Same as HCV RNA This distinction is essential. Test What It Detects Main Meaning **Anti-HCV Rapid Test** Antibodies to HCV Evidence of previous or current exposure **HCV RNA Test** Viral RNA Evidence of current viraemic infection **HCV Core Antigen** HCV core antigen May support detection of current infection in appropriate algorithms A reactive anti-HCV rapid test is therefore **a screening result, not a complete diagnosis of active hepatitis C**. # Key Product Features ## Anti-HCV Antibody Screening The Microsidd HCV Rapid Test is designed for qualitative detection of: **Antibodies to Hepatitis C Virus** ## 50-Test Professional Pack Each institutional sales pack contains: **50 tests** making it appropriate for laboratories, hospitals, clinics and screening programmes with higher testing requirements. ## Rapid Lateral-Flow Format The immunochromatographic format supports rapid visual screening without requiring an ELISA reader. ## Single-Use Tests Each test device is intended for **one specimen and one test only**. ## Professional IVD Use This 50-test listing is intended for trained healthcare and laboratory personnel rather than unsupervised home self-testing. # Technical Specifications Specification Details **Brand** Microsidd **Product** HCV Rapid Test Kit **Pack Size** 50 Tests **Target Marker** Anti-HCV Antibodies **Disease Area** Hepatitis C **Test Type** Qualitative Rapid Screening **Technology** Lateral Flow Immunochromatography **Format** Rapid Test Device / Cassette, as supplied **Result Classification** Reactive / Non-Reactive / Invalid according to IFU **Single Use** Yes **Intended Users** Trained Healthcare & Laboratory Personnel **Intended Use** Professional IVD **Specimen** Verify exact current IFU **Reading Time** Verify exact current IFU **Storage** Verify carton label / current IFU # How the HCV Rapid Test Works The test uses a membrane-based immunochromatographic principle. During testing: 1. The specified specimen is added to the test device. 2. Assay buffer is added where required. 3. The specimen migrates through the membrane. 4. Anti-HCV antibodies, when present above the assay detection threshold, interact with assay reagents. 5. A visible test indicator may develop. 6. A valid control indicator must also appear. The exact procedure and line interpretation must follow the current package insert supplied with the test. # General Professional Testing Workflow A typical professional testing sequence is: 1. Verify product name, lot number and expiry date. 2. Inspect the individual foil pouch. 3. Review the current Instructions for Use. 4. Prepare the permitted specimen. 5. Open the test device only when ready to perform the assay. 6. Add the specified amount of specimen. 7. Add the required buffer where applicable. 8. Allow the assay to develop for the stated period. 9. Read within the manufacturer-defined interpretation window. 10. Record the result. 11. Dispose of the used test and specimen-contact materials according to biosafety procedures. Do not copy sample volume, number of buffer drops or reading time from another HCV test simply because the cassettes look similar. # Result Interpretation ## Non-Reactive A valid non-reactive result generally means that the required control indicator appears and the test does not detect anti-HCV antibodies under the assay conditions. A non-reactive result does not exclude infection in every circumstance, particularly after **recent exposure before antibodies have become detectable**. ## Reactive A reactive result means that **anti-HCV antibodies have been detected**. This can occur in someone with: - current HCV infection - previous HCV infection that has cleared - occasionally another situation requiring further assessment A reactive antibody result should therefore proceed to appropriate follow-up testing. ## Invalid If the required control indicator does not appear, the test is invalid. The specimen should be retested using a new device according to the IFU. # What Should Happen After a Reactive HCV Antibody Test? A reactive anti-HCV result should generally be followed by testing that determines whether **current HCV infection is present**. This commonly involves: **HCV RNA / NAT testing** The follow-up pathway should be determined by qualified healthcare professionals and the applicable clinical/testing protocol. # HCV Screening vs Current Infection Stage Test Purpose **Initial Screening** Anti-HCV Antibody Test Detects antibodies indicating exposure **Current Infection Assessment** HCV RNA / NAT Detects active viraemia **Clinical Evaluation** Additional Laboratory / Medical Assessment Evaluates liver health and treatment needs The Microsidd HCV Rapid Test performs the **initial antibody-screening step**. # Who Can Use This Product? The Microsidd HCV 50 Test Pack is intended for appropriately trained personnel working in settings such as: - Diagnostic laboratories - Pathology laboratories - Hospitals - Clinics - Hepatology / gastroenterology services - Public-health programmes - Antenatal healthcare programmes - Institutional screening programmes - Occupational-health settings - Medical colleges - Blood-bank environments where the test’s intended use and applicable regulations permit This product is **for professional IVD use only**. # Professional Applications The test may support appropriate workflows for: - Hepatitis C antibody screening - Clinical infectious-disease screening - Antenatal infection screening - Institutional screening - Public-health programmes - Occupational-health programmes - Healthcare exposure assessment where clinically indicated - Other professional HCV screening pathways # HCV Testing During Pregnancy Hepatitis C screening can be relevant during antenatal care. Antenatal care provides an opportunity to identify maternal HCV exposure and, where the antibody screen is reactive, arrange appropriate follow-up testing to determine whether current infection is present. A reactive **anti-HCV antibody result during pregnancy does not by itself establish active HCV infection**. Follow-up testing and maternal care should be coordinated by qualified healthcare professionals. # Professional Maternal & Infectious Disease Testing Hub The **Microsidd HCV Rapid Test Kit – 50 Tests** forms part of the broader **Microsidd Maternal & Infectious Disease Rapid Testing Hub**, which connects professional infectious-disease screening with the antenatal-care pathway. ## Antenatal Infection Screening: HIV, Syphilis, HBsAg & HCV [https://microsidd.com/blogs/knowledge-hub/antenatal-infection-screening-hiv-syphilis-hepatitis-b-hcv](https://microsidd.com/blogs/knowledge-hub/antenatal-infection-screening-hiv-syphilis-hepatitis-b-hcv?utm_source=chatgpt.com) The Microsidd professional maternal-testing architecture is: **Pregnancy Confirmed** ↓ **First Antenatal Visit** ↓ **Maternal & Infectious Disease Screening** ↓ **HIV • Syphilis • HBsAg • HCV** ↓ **Individual Professional Screening Guides** ↓ **Professional Rapid-Test Products** ↓ **Confirmatory / Laboratory Testing Where Required** ## HCV Screening HCV rapid tests commonly screen for **anti-HCV antibodies**. A reactive anti-HCV result requires appropriate follow-up, generally including **HCV RNA testing**, to determine whether current infection is present. ## HIV Screening Professional HIV rapid tests may screen for HIV-1/HIV-2 antibodies or other HIV-related markers depending on the assay. A reactive screening result must follow the applicable HIV testing algorithm. ## HBsAg / Hepatitis B Screening HBsAg testing detects **hepatitis B surface antigen** and is different from hepatitis B antibody testing. ## Syphilis Screening Syphilis rapid tests commonly detect antibodies associated with _Treponema pallidum_. Interpretation and follow-up depend on the exact test and the applicable clinical algorithm. ## Important Maternal-Health Distinction HIV, syphilis, hepatitis B and hepatitis C are **four separate infections**. They may be considered together within antenatal infection-screening pathways, but: **one test cannot be used to infer the result of another infection.** HCV should also not be described as part of WHO’s HIV–syphilis–hepatitis B **Triple Elimination** framework; it is an additional important infectious-disease screening consideration according to applicable guidance. # Related Microsidd Professional Testing Resources ### Antenatal Infection Screening Guide [https://microsidd.com/blogs/knowledge-hub/antenatal-infection-screening-hiv-syphilis-hepatitis-b-hcv](https://microsidd.com/blogs/knowledge-hub/antenatal-infection-screening-hiv-syphilis-hepatitis-b-hcv?utm_source=chatgpt.com) ### Rapid Diagnostic Tests [https://microsidd.com/collections/rapid-test](https://microsidd.com/collections/rapid-test?utm_source=chatgpt.com) ### Blood Bank Range [https://microsidd.com/collections/blood-bank-range](https://microsidd.com/collections/blood-bank-range) ### Existing Microsidd HCV Rapid Test [https://microsidd.com/products/hcv-rapid-test-kit](https://microsidd.com/products/hcv-rapid-test-kit?utm_source=chatgpt.com) Once the new HIV and HBsAg 50T URLs are live, also interlink: **Microsidd HIV 1 & 2 Rapid Test 50T** ↕ **Microsidd HBsAg Rapid Test 50T** ↕ **Microsidd HCV Rapid Test 50T** ↕ **Microsidd Syphilis Rapid Test 50T** This creates the professional infection-screening cluster. # Storage & Handling Follow the exact conditions printed on the product carton and current package insert. General good practice includes: - keep the kit in its original packaging - protect from moisture - avoid excessive heat - do not use after expiry - do not use damaged foil pouches - open the test device only when ready to test - do not reuse test devices - keep assay buffer properly closed - maintain lot traceability - follow institutional reagent-storage procedures The supplied IFU overrides general website guidance. # Transportation During transportation: - maintain manufacturer-defined temperature conditions - protect kits from moisture - avoid excessive heat - avoid freezing unless specifically allowed - protect cartons and foil pouches from damage - preserve lot and expiry traceability # Quality Control Professional testing programmes should follow appropriate quality-assurance procedures including: - expiry verification - lot verification - control-line assessment - external controls where required - operator training - environmental-condition monitoring - laboratory SOPs - documentation of results Do not report an invalid test. # Why Buy Microsidd HCV Rapid Test – 50 Tests? Microsidd India supplies professional rapid diagnostic tests, blood-bank products and laboratory diagnostics to healthcare professionals and institutions. Benefits include: ✓ Microsidd professional infectious-disease range ✓ 50-test institutional pack ✓ Integration with Microsidd maternal and infectious-disease content ✓ Related HIV, HBsAg and syphilis screening products ✓ Bengaluru-based customer support ✓ GST invoice where applicable ✓ Institutional supply support subject to availability ✓ Online ordering across serviceable locations in India ✓ Clear screening-versus-confirmation guidance # Buy HCV Rapid Test Kit in Bangalore / Bengaluru Microsidd India supplies **professional HCV rapid test kits in Bengaluru** and serves laboratories, hospitals, clinics and institutional healthcare customers across serviceable locations in India. Relevant search phrases include: **HCV rapid test Bangalore** **Hepatitis C test kit Bengaluru** **HCV rapid test 50 tests India** **anti-HCV rapid test Bangalore** **professional HCV test kit Bengaluru** **Hepatitis C antibody test near me** # Microsidd India – NAP **Business Name:** Microsidd India **Address:** #09, Green Chambers, 14th Cross, RT Nagar, Bengaluru – 560032, Karnataka, India **Phone / WhatsApp:** +91 63667 72288 **Email:** [support@microsidd.com](mailto:support@microsidd.com) **Website:** [https://microsidd.com](https://microsidd.com) **Working Hours:** Monday to Saturday, 10:00 AM – 6:00 PM IST # Find Microsidd India on Google Maps [https://www.google.com/maps/search/?api=1&query=Microsidd+India%2C+09+Green+Chambers%2C+14th+Cross%2C+RT+Nagar%2C+Bengaluru+560032](https://www.google.com/maps/search/?api=1&query=Microsidd+India%2C+09+Green+Chambers%2C+14th+Cross%2C+RT+Nagar%2C+Bengaluru+560032) # Stay Connected with Microsidd ## Subscribe to Microsidd on YouTube [https://www.youtube.com/channel/UCun9gCID17Z5kK65W6JtIdg?sub\_confirmation=1](https://www.youtube.com/channel/UCun9gCID17Z5kK65W6JtIdg?sub_confirmation=1) ## Follow the Microsidd WhatsApp Channel [https://whatsapp.com/channel/0029Va5lCoi1nozBZBL1gx3P](https://whatsapp.com/channel/0029Va5lCoi1nozBZBL1gx3P) # Frequently Asked Questions ### What does the Microsidd HCV Rapid Test detect? It is designed for qualitative screening for **antibodies to Hepatitis C Virus – anti-HCV**. ### What pack size is this? **50 tests.** ### Does the rapid test directly detect HCV virus? This product should be described as an **anti-HCV antibody screening test**, not as a direct HCV RNA test. ### Does a reactive HCV antibody result confirm current hepatitis C? No. A reactive antibody result indicates previous exposure to HCV but does not by itself establish whether current viraemic infection is present. ### What test confirms current HCV infection? Appropriate nucleic-acid testing for: **HCV RNA** is commonly used to establish current infection. ### Can someone remain anti-HCV reactive after clearing infection? Yes. HCV antibodies may remain detectable even when the person no longer has active infection. ### Can this test measure HCV viral load? No. HCV viral-load assessment requires molecular testing. ### Can this test determine HCV genotype? No. Genotype assessment requires separate laboratory testing where clinically required. ### Is this test relevant during pregnancy? HCV screening can form part of antenatal infection-screening pathways according to applicable guidance and clinical protocols. ### Does a reactive result during pregnancy mean the baby is infected? No. A maternal reactive antibody screen does not determine infant infection status. Further maternal testing and appropriate infant follow-up are required. ### Is HCV part of WHO’s Triple Elimination programme? The WHO Triple Elimination framework focuses on: **HIV, syphilis and hepatitis B.** HCV is a separate infection that may also be considered in antenatal screening according to applicable guidelines. ### Is this product intended for home self-testing? No. This listing is for **professional IVD use only**. ### Which specimens can be used? Use only the specimen types specified in the exact package insert supplied with the current 50-test batch. ### How much specimen is required? Follow the current Microsidd HCV IFU. ### How many buffer drops should be used? Use only the buffer quantity specified in the package insert. ### How long should I wait before reading the result? Follow the exact manufacturer-defined reading window printed in the current IFU. ### What does an invalid result mean? If the required control indicator does not appear, the test cannot be interpreted and should be repeated with a new device. ### Can an expired HCV rapid test be used? No. ### Can the test device be reused? No. Each device is single use. # No Return / No Exchange Policy **This product is non-returnable and non-exchangeable.** Please verify the **product name, test marker, pack size, specimen requirements, intended use and product specifications before placing your order**. Professional customers should verify that the test configuration is suitable for their laboratory, hospital or institutional testing protocol. Genuine cases involving an **incorrect product received** will be handled separately according to Microsidd.com's applicable policies and applicable law. **An original, continuous, unedited and uncut unboxing video is compulsory for making any claim regarding an incorrect product received.** # Medical / Professional Disclaimer The **Microsidd HCV Rapid Test Kit – 50 Tests is intended for professional in-vitro diagnostic screening use only**. A reactive anti-HCV result is **not sufficient by itself to establish current hepatitis C infection**. Reactive results should undergo appropriate follow-up testing, generally including HCV RNA testing, according to the applicable clinical and laboratory pathway. A non-reactive result does not exclude every possible recent exposure. Pregnancy-related testing and management should be supervised by qualified healthcare professionals. All patient specimens and used test materials should be considered potentially infectious and handled according to appropriate biosafety procedures. ## Details - **Price:** 999.0 INR - **Vendor:** MicroSidd ## Variants | Variant | Price | Available | |---------|-------|-----------| | Default Title | 999.00 INR | In stock | ## Images - Microsidd HIV 1 & 2 Rapid Test Kit – 50 Tests - Buy Microsidd HCV Rapid Test Kit 50 tests for professional qualitative anti-HCV antibody screening - Buy Microsidd HCV Rapid Test Kit 50 tests for professional qualitative anti-HCV antibody screening - Buy Microsidd HCV Rapid Test Kit 50 tests for professional qualitative anti-HCV antibody screening - Buy Microsidd HCV Rapid Test Kit 50 tests for professional qualitative anti-HCV antibody screening --- > Source: [Microsidd India](https://microsidd.com/products/microsidd-hcv-rapid-test-kit-50-tests) > Updated: 2026-10-02